Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 158

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

The Neurosteroid, 3α‐Hydroxy‐5α‐pregnan‐20‐one, Protects against Bicuculline‐Induced Seizures during Ethanol Withdrawal in Rats

Devaud, Leslie L., Purdy, Robert H., Morrow, A. Leslie · 1995 · Alcoholism: Clinical and Experimental Research

Abstract

Prolonged alcohol consumption leads to the development of tolerance to and dependence on ethanol, resulting in a decreased response to the sedative/hypnotic effects of ethanol, and by negative symptomatology following abrupt termination of use. One symptom associated with ethanol withdrawal in humans, as well as laboratory animals, is enhanced susceptibility to seizures. This study investigated the effects of the neurosteroid, 3α‐hydroxy‐5α‐pregnan‐20‐one (3α‐5α‐THP), on alterations in seizure sensitivity associated with ethanol withdrawal. 3α‐5α‐THP is a potent anxiolytic and anticonvulsant agent that acts via selective interactions with GABA A receptors. Extensive evidence suggests that some aspects of ethanol dependence and withdrawal are mediated by alterations in GABA A receptor function. Withdrawal from chronic ethanol exposure elicited dramatic increases in seizure susceptibility in male and female rats. Administration of 3α‐5α‐THP just before seizure threshold determinations blocked the increased seizure susceptibility induced by ethanol withdrawal. Ethanol‐withdrawn animals were protected by 3α‐5α‐THP at a dose that had no effect on control animal seizure thresholds. Moreover, male and female rats displayed differential responses to the seizure‐threshold lowering effects of ethanol withdrawal, as well as the protection by 3α‐5α‐THP pretreatment. These findings suggest that there are gender differences associated both with ethanol withdrawal as well as the protection by 3α‐5α‐THP in ethanol‐dependent rats.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1530-0277.1995.tb01514.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Research works printed but not linked: 49

  1. Harrison NL, 1987, Structure‐activity relationships for steroid interaction with the gamma‐aminobutyric acid‐A receptor complex, J Pharmacol Exp Ther, 241, 346
  2. 10.1016/0014-2999(87)90094-X · DOI · Paper page
  3. 10.1016/0014-2999(87)90317-7 · DOI · Paper page
  4. Morrow AL, 1990, Characterization of steroid interactions with gamma‐aminobutyric acid receptor‐gated chloride ion channels: Evidence for multiple steroid recognition sites, Mol Pharmacol, 37, 263
  5. 10.1021/jm00168a008 · DOI · Paper page
  6. 10.1016/0006-8993(86)91500-3 · DOI · Paper page
  7. 10.1016/0006-8993(91)90761-J · DOI · Paper page
  8. 10.1016/0006-8993(91)91658-N · DOI · Paper page
  9. 10.1016/0091-3057(93)90260-Z · DOI · Paper page
  10. 10.1016/0014-2999(89)90077-0 · DOI · Paper page
  11. Finn DA, 1994, Estrus cycle and sensitivity to convulsants and the anticonvulsant effect of a neurosteroid, J Pharmacol Exp Ther, 271, 164
  12. 10.1016/0039-128X(90)90031-6 · DOI · Paper page
  13. 10.1111/j.1365-2826.1991.tb00273.x · DOI
  14. 10.1096/fasebj.6.6.1347506 · DOI · Paper page
  15. Purdy RH, 1991, Fidia Research Foundation Symposium Series, 95
  16. 10.1210/endo.133.3.8365352 · DOI · Paper page
  17. 10.1016/0022-4731(85)90147-5 · DOI
  18. Morrow AL, 1990, Neuropharmacology of Ethanol: New Advances, 50
  19. Morrow AL, 1988, Chronic ethanol administration alters γ‐aminobutyric acid, pentobarbital and ethanol‐mediated 36Cl‐ uptake in cerebral cortical synaptoneurosomes, J Pharmacol Exp Ther, 246, 158
  20. Allan AM, 1992, Effects of lorazepam tolerance and withdrawal on GABAA receptor‐operated chloride channels, J Pharmacol Exp Ther, 261, 395
  21. Lê AD, 1992, Effects of chronic treatment with ethanol on the development of cross‐tolerance to other alcohols and pentobarbital, J Pharmacol Exp Ther, 263, 480
  22. Mihic SJ, 1992, Role of the gamma‐aminobutyric acid receptor/chloride channel complex in tolerance to ethanol and cross‐tolerance to diazepam and pentobarbital, J Pharmacol Exp Ther, 261, 108
  23. 10.1056/NEJM197604012941405 · DOI · Paper page
  24. 10.1016/0006-3223(88)90023-6 · DOI · Paper page
  25. Frye GD, 1983, Differential sensitivity of ethanol withdrawal signs in the rat to γ‐aminobutyric acid (GABA) mimetics: Blockade of audiogenic seizures but not forelimb tremors, J Pharmacol Exp Ther, 226, 720
  26. Goldstein DB, 1973, Alcohol withdrawal reactions in mice: Effects of drugs that modify neurotransmission, J Pharmacol Exp Ther, 186, 1
  27. Criswell HE, 1993, Chronic ethanol decreases the ability of GABA to inhibit ethanol‐sensitive neurons in the medial septum, Alcohol Clin Exp Res, 17, 477
  28. Mhatre MC, 1993, Chronic ethanol administration alters γ‐aminobutyric acidA receptor gene expression, Mol Pharmacol, 42, 415
  29. 10.1111/j.1530-0277.1993.tb00735.x · DOI · Paper page
  30. 10.1016/0006-8993(89)90011-5 · DOI
  31. Buck KJ, 1990, Benzodiazepine agonist and inverse agonist actions on GABAA receptor‐operated chloride channels. II. Chronic effects of ethanol, J Pharmacol Exp Ther, 253, 713
  32. 10.1111/j.2042-7158.1978.tb13259.x · DOI · Paper page
  33. 10.1111/j.1530-0277.1984.tb05712.x · doi:10.1111/j.1530-0277.1984.tb05712.x
  34. 10.1016/0741-8329(92)90092-O · DOI
  35. 10.1016/0091-3057(92)90005-Z · DOI
  36. 10.1111/j.1530-0277.1993.tb00853.x · DOI
  37. Finn DA, 1994, Chronic ethanol differentially alters neurosteroids in withdrawal seizure prone and resistant mice, Alcohol Clin Exp Res, 18, 448
  38. 10.1016/1044-7431(92)90045-4 · DOI
  39. Goldstein D, 1972, Relationship of alcohol dose to intensity of withdrawal signs in mice, J Pharmacol Exp Ther, 180, 203
  40. 10.1016/0361-9230(92)90022-P · DOI
  41. 10.1016/0091-3057(92)90174-E · DOI
  42. 10.1016/0741-8329(92)90062-F · DOI
  43. 10.1111/j.1471-4159.1993.tb03507.x · DOI
  44. 10.1136/jnnp.49.1.47 · DOI · Paper page
  45. 10.1111/j.1476-5381.1991.tb09830.x · DOI
  46. Finn DA, 1993, The influence of estrus cycle on neurosteroid potency at the gamma‐aminobutyric acidA receptor complex, J Pharmacol Exp Ther, 265, 1374
  47. 10.1016/0014-2999(86)90501-7 · DOI
  48. 10.1016/0014-2999(89)90535-9 · DOI
  49. 10.1016/0091-3057(91)90151-Q · DOI

Cited by

See all 158

Metadata

Authors
Devaud, L. L., Purdy, R. H., & Morrow, A. L.
Venue
Alcoholism: Clinical and Experimental Research
Publisher
Wiley
Published
1995-04
Volume
19
Issue
2
Pages
350-355
ISSN
  • 0145-6008 (ISSN-L)
  • 1530-0277
OpenAlex
W2076787408
Cited by
158
References
4
FWCI
6.02
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Neurosteroid, 3α‐Hydroxy‐5α‐pregnan‐20‐one, Protects against Bicuculline‐Induced Seizures during Ethanol Withdrawal in Rats. https://app.cochat.ai/papers/10.1111/j.1530-0277.1995.tb01514.x
The paper
Devaud, L. L., Purdy, R. H., & Morrow, A. L. (1995). The Neurosteroid, 3α‐Hydroxy‐5α‐pregnan‐20‐one, Protects against Bicuculline‐Induced Seizures during Ethanol Withdrawal in Rats. Alcoholism: Clinical and Experimental Research. https://doi.org/10.1111/j.1530-0277.1995.tb01514.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.